Skip to main content

Table 1 Demographic and clinical details of patients treated with adalimumab

From: Adalimumab - an effective and promising treatment for patients with fistulizing Crohn's disease: a case series

Number Case Luminal + FCD Fistula type Previous failed and/or intolerant therapies Current treatment Adverse effects Treatment outcome
1 44, M ileo-colonic CD Yes Enterocutaneous, post-operative Parenteral nutrition Antibiotics - ciprofloxacine and metronidazole Adalimumab monotherapy [160-80-40] no Luminal disease remission Fistula healing
3 20, F ileo-colonic CD peri-anal disease Yes Peri-anal Corticosteroid resistant Antibiotics - ciprofloxacine and metronidazole Azathioprine (fever and pancreatitis) Methotrexate (hepatitis) Reaction to infliximab (laryngismus) Corticosteroids (tapered off) plus Adalimumab [160-80-40] Seton drainage no Luminal disease remission Fistula healing
2 18, F ileo-colonic CD Yes Enterocutaneous, post-operative No Adalimumab monotherapy [160-80-40] no Luminal disease remission Fistula healing
  1. CD: Crohn's disease; M: male; F: female
Back to article page